Neonatal Eye Defects and Stem Cell Therapeutics

Abstract

Present review aims to describe various neonatal eye defects and its stem cell therapeutics. This article attempts to highlight common causes of visual impairment in infants and present the recent approaches used for restoration of normal vision in patients. The article highlights the need for setting microenvironment or stem cell micro niche for regeneration of opticneural complexes. Till date no proven drug based treatment existed for inherited eye defects. By adopting different therapeutic measures causal effects can be improved. The article advocates cell based therapeutics for wound healing of optical tissues for functional restoration using appropriate and suitable cell transplantations in animal models. In addition, possible solutions have been suggested to reduce the pain in newborns and infants from serious life-threatening visual complications or infection induced visual pathogenesis. This article emphasizes use of stem cell derived lens cells for human lens development and regeneration of corneal and retinal cells for increasing future therapeutic applications. As an alternative remedy exploring and designing new biomaterials to make matrix based nano-structure constructs for corneal repair and regeneration has been suggested. Bioengineered corneal devices are addressed with safe use of tissue-engineered hydrogels to allow regeneration of radiosensitivity in neural-visual cell complex. Present review presents new advancements in the field of biocompatible substrates, bio-matrix, transplantation methods and micro-niche maintaining factors for restoration, repairing and healing of visual-neuroepithelial complexes successfully.

Authors and Affiliations

Ravi Kant Upadhyay

Keywords

Related Articles

Indirect Co-Culture with Schwann Cells as a New Approach for Human Endometrial Stem Cells Neural Transdifferentiation

Neurodegenerative diseases such as Spinal Cord Injury (SCI) refer to the loss of neuronal cells in the central nervous system. Cell replacement therapy is currently the most propitious approach for the treatment of such...

Re-Engraftment of Prior Cord Blood Graft in a Patient with Relapsed/Refractory Acute Myeloid Leukaemia following Haploidentical Transplantation

We report the case of a 32-year-old man with poor risk acute myeloid leukemia (AML) who received transplantation of an UCB graft following myeloablative conditioning but unfortunately relapsed after one year with complet...

Circulating Endothelial Progenitor Cells in Women with Coronary Microvascular Dysfunction: A Pilot Study

Background: Endothelial progenitor cells (EPCs) are a diverse population of mononuclear cells derived from bone marrow that are mobilized in response to vascular injury, circulate in peripheral blood and contribute to va...

Isolation Stem Cells From Human Dental Pulps And Differentiation Them To Adiposite And Osteoblast

Objective: in this study we tried to isolated stem cells from human primary dental pulp. These cells are capable of differentiating into a variety of cell types including neural cells, adipocytes, and odontoblasts, osteo...

Regulations of Regenerative Medicine Including Clinical Application of iPS Cells in Japan

Clinical studies of regenerative medicine using induced pluripotent stem (iPS) cells have recently been performed, especially in Japan. To promote regenerative medicine research using iPS cells, the related laws have bee...

Download PDF file
  • EP ID EP198042
  • DOI 10.19070/2328-3548-1600032
  • Views 98
  • Downloads 0

How To Cite

Ravi Kant Upadhyay (2016). Neonatal Eye Defects and Stem Cell Therapeutics. International Journal of Stem Cell Research and Transplantation (IJST), 4(6), 195-215. https://europub.co.uk/articles/-A-198042